Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT)-Reference-Cited by-同舟云学术

Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT)

Published:2018-07 Issue:4 Volume:101 Page:900-909
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Murray Louise J.,Sykes Jenna,Brierley James,Kim John J.,Wong Rebecca K.S.,Ringash Jolie,Craig Tim,Velec Michael^ORCID,Lindsay Patricia,Knox Jennifer J.,Dawson Laura A.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference25 articles.

1. Stereotactic body radiation therapy (SBRT) for early-stage primary liver cancer (HCC);Schulz;Appl Radiat Oncol,2013

2. Assessment of prognosis of cirrhosis;Durand;Semin Liver Dis,2008

3. Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: The ALBI scoring model;Knox;J Clin Oncol,2015

4. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade;Johnson;J Clin Oncol,2015

5. Surgery and portal hypertension;Child;Major Probl Clin Surg,1964

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery;Strahlentherapie und Onkologie;2024-07-12

2. Albumin–bilirubin score is a useful predictor of worsening liver reserve after stereotactic body radiation therapy in elderly Japanese patients with hepatocellular carcinoma;Journal of Radiation Research;2024-02-26

3. Time variation of high-risk groups for liver function deteriorations within fluctuating long-term liver function after hepatic radiotherapy in patients with hepatocellular carcinoma;European Journal of Medical Research;2024-02-07

4. Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month;European Journal of Radiology;2024-01

5. Evolution of Response-Based Radiotherapy for Hepatocellular Cancer;The Cancer Journal;2023-09